SCP
RMTI icon

Sandhill Capital Partners’s Rockwell Medical RMTI Stock Holding History

Sandhill Capital Partners’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-91
Closed -$11K – 89
2020
Q3 		$11K Buy
+91
New +$15.7K ﹤0.01% 81

Other funds holding RMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Sandhill Capital Partners's RMTI Position: Q4 2020 in Review

Sandhill Capital Partners sold out of Rockwell Medical (RMTI) in Q4 2020, closing a stake of 91 shares — an estimated $11K sold.

Sandhill Capital Partners first reported a position in RMTI in Q3 2020 and held it in 1 quarter. The position peaked at $11K in Q3 2020. 91 funds tracked by Wall St. Rank hold RMTI as of Q4 2020.

  • Sandhill Capital Partners reported no remaining Rockwell Medical position as of Q4 2020 after selling out during the quarter.
  • Sandhill Capital Partners sold 91 Rockwell Medical shares in Q4 2020, an estimated $11K.
  • Sandhill Capital Partners first reported a position in Rockwell Medical in Q3 2020 and held it in 1 quarter.
  • Sandhill Capital Partners's Rockwell Medical position peaked at $11K in Q3 2020.
  • 91 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2020.

Based on Sandhill Capital Partners's 13F filing for Q4 2020, filed 12 Feb 2021.